Third quarter total revenue of $1,229.8 million, up 4.4% year over year as reported and 4.2% in constant currency Third quarter Enterprise revenue of $741.4 million, up 6.1% year over year Third quarter GAAP operating margin of 25.2% and non-GAAP operating margin of 41.2% Third quarter operating cash flow of $629.3 million, up 30.2% year over year Third quarter operating cash flow margin of 51.2% and free cash flow margin of 50.0% Third quarter GAAP EPS of $2.01, up 204.5% year over year, and non-GAAP EPS of $1.52, up 10.1% year over year Number of customers contributing more than $100,000 in trailing 12 months revenue up 9.2% year over year Repurchased approximately 5.1 million shares of common stock in Q3, bringing the total shares repurchased under the current plan to 32.5 million Increased total common stock repurchase authorization...

WILMINGTON, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) — Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, announced financial results for its fourth fiscal quarter and fiscal year 2025, which ended on September 27, 2025. Symbotic reported revenue of $618 million, a net loss of $19 million and adjusted EBITDA1 of $49 million for the fourth quarter of fiscal year 2025. In comparison, Symbotic posted revenue of $565 million, net income of $16 million and adjusted EBITDA1 of $42 million in the fourth quarter of fiscal year 2024. Cash and cash equivalents increased by $467 million from the prior quarter, totaling $1,245 million at the end of the fourth quarter of fiscal year 2025. For the full fiscal year 2025, Symbotic reported revenue of $2,247 million, reflecting 26% growth year-over-year,...

Reykjavík Energy‘s (Orkuveita Reykjavíkur) Board of Directors approved today the interim financial statements for the first nine months of 2025. The consolidated profit amounted to ISK 6.7 billion, compared to ISK 5.1 billion in the same period in 2024 — an improvement of 31%. Operating revenues increased by 3.9% year-on-year, while operating expenses rose by 2.0%. The interim financial statements cover the Reykjavík Energy Group, which includes, in addition to the parent company, Veitur Utilities, ON Power, Reykjavík Fibre Network, and Carbfix. Solid Financial Position “We want to respond to the government’s call for increased resilience and security in the community’s basic infrastructure. We have therefore emphasised expanding energy generation, particularly for Veitur Utilities’ district heating systems, but also on increasing sustainable...

LIMASSOL, Cyprus, Nov. 24, 2025 (GLOBE NEWSWIRE) — GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”), released its unaudited financial and operational results for the third quarter and first nine months ended September 30, 2025. Third quarter 2025 financial highlights:Revenue of $98 million decreased by 12% year-over-year. Selling and marketing expenses of $30 million decreased by 43% year-over-year. Profit for the period, net of tax, of $24 million in Q3 2025 increased vs. $15 million in Q3 2024. Adjusted EBITDA1 of $26 million in Q3 2025 increased vs. $17 million in Q3 2024.Third quarter and first nine months of 2025 financial performance in comparisonUS$ million   Q3 2025   Q3 2024   Change (%)   9M 2025   9M 2024   Change (%)  Revenue   98     111     (12 ) % 315     323     (3 ) %Platform...

Record Fiscal 2025 Financial Performance: Record net revenues of $107.3 million, adjusted EBITDA of $28.1 million1, net income of $13.1 million, operating cash flow of $20 million and free cash flow of $13.7 million1 for Fiscal 2025. Stronger Balance Sheet and Earnings Quality: First year of positive retained earnings as at August 31, 2025, supported by continued free cash flow generation and lower leverage. Continued Market Share Expansion: National market share rose to 3.81% in Fiscal 2025, up 32% year over year, and climbed further to 4.1% in October 20252. Annual General Meeting of shareholders scheduled for January 29, 2026, at 11:00 a.m. EST.All financial results are reported in Canadian dollars, unless otherwise stated. MONTREAL, Nov. 24, 2025 (GLOBE NEWSWIRE) — Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or...

60% Revenue Growth, 59% Gross Margin, and 25% EBITDA Margin ST. JOHN’S, Newfoundland and Labrador, Nov. 24, 2025 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (TSX-V: PNG, OTCQB: KRKNF) (“Kraken” or the “Company”), announced it has filed its financial results for the quarter ended September 30, 2025 (“Q3 2025”). Please refer to the unaudited Condensed Consolidated Interim Financial Statements and Management’s Discussion and Analysis (“MD&A”) for quarter ended September 30, 2025, filed on www.sedarplus.ca for more information. Unless otherwise specified, all dollar amounts are denominated in Canadian dollars.  Q3 2025 Financial HighlightsConsolidated revenue in Q3 2025 increased 60% to $31.3 million, compared to $19.6 million in the prior year. The growth was driven by record shipments of subsea batteries...

Transformation efforts drive performance improvements at Obagi Medical with accelerating revenue Contrasted performance for Milk Makeup with Q2 2025 net revenue growth driven by U.S. channel expansion and sell-out acceleration but softer performance in Q3 2025 in international markets Company advances key strategic initiatives, including expansion into medical aesthetics through the Novaestiq acquisition and strengthened balance sheet following the sale of the Obagi Japan trademark and credit facility refinancing Waldencast updates FY 2025 guidance to reflect current trends and purposeful investments to drive long-term growth LONDON, Nov. 24, 2025 (GLOBE NEWSWIRE) — Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today reported operating results for the three months...

Delivered 4,612 vehicles1 and achieved total revenue of $356 million in first nine months of 2025. Gross margin improved to 8% in the third quarter, reflecting healthier inventory dynamics and continued recovery in underlying profitability. Net loss narrowed by approximately 68% in the third quarter and 43% for the nine-month period ended September 30, 2025, on a YoY basis. Upcoming launch of new PHEV model reaffirming commitment to diversified energy strategy.NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — Lotus Technology Inc. (“Lotus Tech” or the “Company”), a leading global intelligent and luxury mobility provider, today announced its unaudited financial results for the third quarter and nine months ended September 30, 2025. Operating Highlights of the First Nine Months of 2025 In the first nine months of 2025, the Company achieved...

WeRide Announces Unaudited Financial Results for Q3 2025 NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD, HKEX:0800), a global leader in autonomous driving technology, today announced its unaudited financial results for the three months ended September 30, 2025. Financial and Operational HighlightsTotal revenue grew 144.3% year-over-year (YoY) to RMB171.0 million (US$24.0 million) in 3Q2025, one of the largest revenue increases in the Company’s history, primarily due to continued global fleet expansion and increasing service penetration.Product revenue and service revenue grew 428.0% and 66.9% YoY to RMB 79.2 million (US$11.1 million) and RMB 91.8 million (US$12.9 million), respectively. 3Q2025 robotaxi revenue grew 761.0% YoY to RMB 35.3 million (US$5.0 million). Robotaxi revenue...

EINDHOVEN, the Netherlands, Nov. 24, 2025 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today announced its results for the third quarter of 2025 and provides a comprehensive business update:Commercial traction: The Company met its objective of 40 ARC-EX® Systems sold in Q3. Regulatory milestones: The US Food and Drug Administration (FDA) approved an investigational device exemption (IDE) for the ARC-IM® System, allowing the initiation of the Empower BP global pivotal study. The Company received CE Mark certification for the ARC-EX System. In November, the FDA also cleared the ARC-EX System for home use in the US. Science...